4/A

PRIMARY DOCUMENT

Company: GYRE THERAPEUTICS, INC.
Filed: November 20, 2012
Period of Report: November 14, 2012
Accession Number: 0001055947-12-000010

View Document ↗ View on SEC.gov ↗